Consolidated Statements of Operations and Comprehensive Income (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2025	Mar. 31, 2024
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 47,328,701	$ 54,808,042
Cost of revenues (including cost of revenues from related parties of $3,456,928 and $1,797,359 for the three months ended March 31, 2025 and 2024, respectively)		9,595,617	15,288,667
Gross profit		37,733,084	39,519,375
Operating expenses:
Selling, general and administrative expenses		13,531,010	15,058,490
Total operating expenses		13,531,010	15,058,490
Income from operations		24,202,074	24,460,885
Other income (expenses):
Interest income		55,333	17,689
Interest expense		(6,207)	(3,008)
Other income		151,328	349,681
Other expenses		(1,697,259)	(1,436,656)
Gain on redemption of life insurance policies		8,746,138
Gain on disposal of subsidiary			3,813,609
Total other income		7,249,333	2,741,315
Income before income taxes		31,451,407	27,202,200
Income tax expense		9,959,457	8,451,984
Net income		21,491,950	18,750,216
Less: net loss attributable to non-controlling interests		(10,496)	(7,536)
Net income attributable to SBC Medical Group Holdings Incorporated		21,502,446	18,757,752
Other comprehensive income (loss):
Foreign currency translation adjustment		9,808,327	(10,193,852)
Total comprehensive income		31,300,277	8,556,364
Less: comprehensive loss attributable to non-controlling interests		(36,832)	(92,000)
Comprehensive income attributable to SBC Medical Group Holdings Incorporated		$ 31,337,109	$ 8,648,364
Net income per share attributable to SBC Medical Group Holdings Incorporated - Basic	[1]	$ 0.21	$ 0.20
Net income per share attributable to SBC Medical Group Holdings Incorporated - Diluted	[1]	$ 0.21	$ 0.20
Weighted average shares outstanding - Basic	[1]	103,276,637	94,192,433
Weighted average shares outstanding - Diluted	[1]	103,276,637	94,192,433
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 45,257,145	$ 50,470,207
Cost of revenues (including cost of revenues from related parties of $3,456,928 and $1,797,359 for the three months ended March 31, 2025 and 2024, respectively)		3,456,928	1,797,359
Nonrelated Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Total revenues, net		$ 2,071,556	$ 4,337,835

[1] Retrospectively restated for effect of reverse recapitalization on September 17, 2024.